VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.19−0.01 (-5.56%)
Close on Nov 17, 2026Market cap $2.58MP/E –Yield –
VolitionRx cash
Cash and short-term investments held at the end of each period.
VolitionRx's cash was $2.80M at Jun 30, 2026. For fiscal 2025 it was $1.12M, down 65.8% from the year before. Over ten years it grew -15.4% a year on average. The highest annual figure on record is $21.68M in fiscal 2016.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12M | -65.8% |
| FY2024 | Dec 31, 2024 | $3.26M | -84.3% |
| FY2023 | Dec 31, 2023 | $20.73M | +90.8% |
| FY2022 | Dec 31, 2022 | $10.87M | -47.2% |
| FY2021 | Dec 31, 2021 | $20.58M | +5.8% |
| FY2020 | Dec 31, 2020 | $19.44M | +14.6% |
| FY2019 | Dec 31, 2019 | $16.97M | +26.4% |
| FY2018 | Dec 31, 2018 | $13.43M | +32.7% |
| FY2017 | Dec 31, 2017 | $10.12M | -53.3% |
| FY2016 | Dec 31, 2016 | $21.68M | +266.4% |
| FY2015 | Dec 31, 2015 | $5.92M | +176.6% |
| FY2014 | Dec 31, 2014 | $2.14M | +140.7% |
| FY2013 | Dec 31, 2013 | $888.70K | +136.1% |
| FY2012 | Dec 31, 2012 | $376.42K | +8.2% |
| FY2011 | Dec 31, 2011 | $347.89K | +632.7% |
| FY2010 | Dec 31, 2010 | $47.48K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.80M | +24.1% |
| Q1 FY2026 | Mar 31, 2026 | $3.10M | +19.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.12M | -65.8% |
| Q3 FY2025 | Sep 30, 2025 | $200.00K | -96.3% |
| Q2 FY2025 | Jun 30, 2025 | $2.26M | -62.4% |
| Q1 FY2025 | Mar 31, 2025 | $2.60M | -77.9% |
| Q4 FY2024 | Dec 31, 2024 | $3.26M | -84.3% |
| Q3 FY2024 | Sep 30, 2024 | $5.41M | -49.9% |
| Q2 FY2024 | Jun 30, 2024 | $6.00M | -69.6% |
| Q1 FY2024 | Mar 31, 2024 | $11.77M | +17.6% |
| Q4 FY2023 | Dec 31, 2023 | $20.73M | +90.8% |
| Q3 FY2023 | Sep 30, 2023 | $10.81M | -34.2% |
| Q2 FY2023 | Jun 30, 2023 | $19.74M | +18.0% |
| Q1 FY2023 | Mar 31, 2023 | $10.01M | -57.8% |
| Q4 FY2022 | Dec 31, 2022 | $10.87M | -47.2% |
| Q3 FY2022 | Sep 30, 2022 | $16.42M | -28.3% |
| Q2 FY2022 | Jun 30, 2022 | $16.73M | -40.1% |
| Q1 FY2022 | Mar 31, 2022 | $23.73M | -28.2% |
| Q4 FY2021 | Dec 31, 2021 | $20.58M | +5.8% |
| Q3 FY2021 | Sep 30, 2021 | $22.90M | +9.4% |
| Q2 FY2021 | Jun 30, 2021 | $27.91M | +31.0% |
| Q1 FY2021 | Mar 31, 2021 | $33.06M | +176.2% |
| Q4 FY2020 | Dec 31, 2020 | $19.44M | +14.6% |
| Q3 FY2020 | Sep 30, 2020 | $20.93M | +6.2% |
| Q2 FY2020 | Jun 30, 2020 | $21.31M | +15.1% |
| Q1 FY2020 | Mar 31, 2020 | $11.97M | -26.0% |
| Q4 FY2019 | Dec 31, 2019 | $16.97M | +26.4% |
| Q3 FY2019 | Sep 30, 2019 | $19.70M | +20.3% |
| Q2 FY2019 | Jun 30, 2019 | $18.51M | +55.6% |
| Q1 FY2019 | Mar 31, 2019 | $16.17M | +13.4% |
| Q4 FY2018 | Dec 31, 2018 | $13.43M | +32.7% |
| Q3 FY2018 | Sep 30, 2018 | $16.37M | +18.3% |
| Q2 FY2018 | Jun 30, 2018 | $11.89M | -27.9% |
| Q1 FY2018 | Mar 31, 2018 | $14.26M | -22.8% |
| Q4 FY2017 | Dec 31, 2017 | $10.12M | -53.3% |
| Q3 FY2017 | Sep 30, 2017 | $13.84M | +10.5% |
| Q2 FY2017 | Jun 30, 2017 | $16.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.47M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.68M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.53M | – |
See a number that looks wrong?